| __timestamp | Amgen Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 15635076 |
| Thursday, January 1, 2015 | 4070000000 | 23943601 |
| Friday, January 1, 2016 | 3840000000 | 23689111 |
| Sunday, January 1, 2017 | 3562000000 | 41006114 |
| Monday, January 1, 2018 | 3737000000 | 51379106 |
| Tuesday, January 1, 2019 | 4116000000 | 32705593 |
| Wednesday, January 1, 2020 | 4207000000 | 53274000 |
| Friday, January 1, 2021 | 4819000000 | 85352000 |
| Saturday, January 1, 2022 | 4434000000 | 51999000 |
| Sunday, January 1, 2023 | 4784000000 | 59471000 |
| Monday, January 1, 2024 | 5964000000 |
In pursuit of knowledge
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for driving innovation and maintaining a competitive edge. Over the past decade, Amgen Inc. has consistently demonstrated its commitment to innovation, investing significantly more in R&D compared to Summit Therapeutics Inc. From 2014 to 2023, Amgen's R&D expenses have averaged around $4.2 billion annually, peaking at approximately $4.8 billion in 2021. In contrast, Summit Therapeutics' R&D spending has been more modest, averaging about $44 million per year, with a high of nearly $85 million in 2021. This stark difference highlights Amgen's robust financial commitment to advancing its research capabilities, outspending Summit by a factor of nearly 100. As the biotech industry continues to evolve, such investments are pivotal in fostering groundbreaking treatments and therapies that can transform healthcare.
Comparing Innovation Spending: Amgen Inc. and Exelixis, Inc.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
R&D Insights: How Summit Therapeutics Inc. and Halozyme Therapeutics, Inc. Allocate Funds
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Summit Therapeutics Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and MiMedx Group, Inc.